Serum IgG subclasses in autoimmune diseases

Medicine (United States)

Volumn 94, Issue 2, 2015, Pages e387-

  Zhang, Haoze ^a   Li, Ping ^a   Wu, Di ^a   Xu, Dong ^a   Hou, Yong ^a   Wang, Qian ^a   Li, Mengtao ^a   Li, Yongzhe ^a   Zeng, Xiaofeng ^a   Zhang, Fengchun ^a   Shi, Qun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FREQUENCY ANALYSIS; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNONEPHELOMETRY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OUTCOME ASSESSMENT; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; BILIARY CIRRHOSIS; BLOOD; CHINA; CLASSIFICATION; MIDDLE AGED; STATISTICAL ANALYSIS;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIVER CIRRHOSIS, BILIARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84921967472     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000387     Document Type: Article

References (36)

1. Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382:819-831.
2. Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. mAbs. 2012;4:17-23.
3. Sigal LH. Basic science for the clinician 58: IgG subclasses. J Clin Rheumatol. 2012;18:316-318.
4. Kapur R, Einarsdottir HK, Vidarsson G. IgG-effector functions: "the good, the bad and the ugly". Immunol Lett. 2014;160:139-144.
5. Kapur R, Einarsdottir HK, Vidarsson G. IgG-effector functions: "The Good, The Bad and The Ugly". Immunol Lett. 2014.
6. Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716-3725.
7. Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev. 2010;9:591-594.
8. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
9. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22:419-425.
10. Ebbo M, Grados A, Bernit E, et al. Pathologies Associated with Serum IgG4 Elevation. Int J Rheumatol. 2012;2012:602809.
11. Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum IgG subclasses in Churg-Strauss syndrome-the meaning of elevated serum levels of IgG4. Intern Med. 2010;49:1365-1370.
12. Blanco F, Kalsi J, Ravirajan CT, et al. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus. 1992;1:391-399.
13. Lin GG, Li JM. IgG subclass serum levels in systemic lupus erythematosus patients. Clin Rheumatol. 2009;28:1315-1318.
14. Liu Y, Li J. Preferentially immunoglobulin (IgG) subclasses production in primary Sjogren's syndrome patients. Clin Chem Lab Med. 2012;50:345-349.
15. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria, Committee. Arthritis Rheum. 1980;23:581-590.
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
18. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology (Baltimore, MD). 2009;50:291-308.
19. Vlug A, Nieuwenhuys EJ, van Eijk RV, et al. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin. 1994;52:561-567.
20. Pressac M, Allouche F, Circaud R, et al. Evaluation of human IgG subclass assays on Beckman array. Ann Clin Biochem. 1995;32 (Pt 3): 281-288.
21. Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol. 2012;26:425-438.
22. Lux A, Nimmerjahn F. Of mice and men: the need for humanized mouse models to study human IgG activity in vivo. J Clin Immunol. 2013;33(Suppl 1):S4-S8.
23. Zhang L, Weetman AP, Jayne DR, et al. Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis. Clin Exp Immunol. 1992;88:56-61.
24. Engelmann R, Brandt J, Eggert M, et al. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology. 2008;47:1489-1492.
25. Alahlafi AM, Wordsworth P, Wojnarowska F. The distribution of IgG subclasses in the lupus band suggests disease-specific alteration in subclass switching rather than polyclonal B-cell activation. Clin Exp Dermatol. 2004;29:288-292.
26. Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis,membranous lupus nephritis,and idiopathic membranous nephropathy. Intern Med (Tokyo, Japan). 2002;41:936-942.
27. Schroeder HW Jr, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S41-S52.
28. Kawasaki Y, Suzuki J, Sakai N, et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis. Am J Kidney Dis. 2004;44:42-49.
29. Eriksson P, Andersson C, Ekerfelt C, et al. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjogren's syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol. 2004;137:617-620.
30. Kang KY, Kim HO, Kwok SK, et al. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther. 2011;13:R179.
31. Rigopoulou EI, Davies ET, Bogdanos DP, et al. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int. 2007;27:1226-1231.
32. Rigopoulou EI, Davies ET, Pares A, et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut. 2005;54:528-532.
33. Yao Q, Wu G, Hoschar A. IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjogren's syndrome: a Caucasian patient and literature review. Clin Exp Rheumatol. 2013;31:289-294.
34. Reddi DM, Cardona DM, Burchette JL, et al. Scleroderma and IgG4-related disease. Am J Dermatopathol. 2013;35:458-462.
35. Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335: 1570-1580.
36. Mavragani CP, Fragoulis GE, Rontogianni D, et al. Elevated IgG4 serum levels among primary Sjogren's syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res. 2014;66:773-777.